Home > Where to buy Ensysce Biosciences stock after its 35% uptick

Where to buy Ensysce Biosciences stock after its 35% uptick

Ensysce Biosciences (NASDAQ: ENSC) is one of today’s best performing stocks. 

Given its recent high-profile news coverage, you may be thinking about investing in Ensysce Biosciences shares. If this is the case, this article can help you make an informed investment. Read on to discover what the company is, what it does, and what the future is likely to hold.

Before we delve into any of these details, check out the section directly below if you want to buy Ensysce Biosciences stock without paying high fees. We have listed the two best places to buy ENSC stock online to make your life a little easier. 

How & where to buy Ensysce Biosciences stock right now

To buy ENSC shares quickly, easily and affordably, simply click on one of the links below, fill out some basic information, finalise the creation for your new account, and fund it from a valid source. Then, you can purchase the number of ENSC shares you want to own.

Here are the best platforms to buy, sell and trade Ensysce Biosciences shares today:


eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.

Register with eToro instantly


Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.

Register with Webull instantly

What is Ensysce Biosciences?

Based in La Jolla, California, it is a clinical-stage biotechnology company that is developing various prescription drugs. Chiefly of which, Ensyce is working on tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products aim to treat severe pain and help prevent deaths caused by the abuse of opioids. 

The ENSC share price has surged following the news that the U.S. Patent and Trademark Office has granted Notice of Allowance for a patent entitled Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof. This could mark the long-awaited first meaningful step in the long road to commercialisation for Ensysce. 

Should I buy Ensysce Biosciences stock today?

If you have analysed the company on both a fundamental and technical level, and you feel growth is on the horizon, buying shares in Ensysce now may be a good move ahead of future growth. Just be cognisant on the risks of investing and the volatility that experimental biotech companies are likely to experience.

Ensysce Biosciences price target 2021

Our 12-month ENSC price target for 2021 is as follows: $15

Trade/invest in stocks with just $50
Invest for dividends and get payout on stocks on Ex-Dividend day
Over 11 payment methods, including PayPal
Open my Account

We use cookies to personalise content & ads, provide social media features and offer you a better experience. By continuing to browse the site or clicking "OK, Thanks" you are consenting to the use of cookies on this website.